Pfizer Unit Fights Loss To MSD In Pneumonia Vaccine IP Case
A Pfizer unit urged an appellate court Wednesday to overturn a decision invalidating the patent for its blockbuster Prevnar 13 pneumonia vaccine, saying a judge "misunderstood" a 2004 paper published by...To view the full article, register now.
Already a subscriber? Click here to view full article